Shi Hong-Ke, Liang Ke-Ling, An Li-Hua, Zhang Bing, Zhang Cheng-Yun
Department of Neonatology, First People's Hospital of Zhengzhou, Zhengzhou 450000, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):295-301. doi: 10.7499/j.issn.1008-8830.2209121.
To systematically evaluate the efficacy and safety of noninvasive high-frequency oscillatory ventilation (NHFOV) versus nasal intermittent positive pressure ventilation (NIPPV) as post-extubation respiratory support in preterm infants.
China National Knowledge Infrastructure, Wanfang Data, Chinese Journal Full-text Database, China Biology Medicine disc, PubMed, Web of Science, and the Cochrane Library were searched for articles on NHFOV and NIPPV as post-extubation respiratory support in preterm infants published up to August 31, 2022. RevMan 5.4 software and Stata 17.0 software were used for a Meta analysis to compare related indices between the NHFOV and NIPPV groups, including reintubation rate within 72 hours after extubation, partial pressure of carbon dioxide (PCO) at 6-24 hours after switch to noninvasive assisted ventilation, and the incidence rates of bronchopulmonary dysplasia (BPD), air leak, nasal damage, periventricular leukomalacia (PVL), intraventricular hemorrhage (IVH), and retinopathy of prematurity (ROP).
A total of 9 randomized controlled trials were included. The Meta analysis showed that compared with the NIPPV group, the NHFOV group had significantly lower reintubation rate within 72 hours after extubation (=0.67, 95%: 0.52-0.88, =0.003) and PCO at 6-24 hours after switch to noninvasive assisted ventilation (=-4.12, 95%: -6.12 to -2.13, <0.001). There was no significant difference between the two groups in the incidence rates of complications such as BPD, air leak, nasal damage, PVL, IVH, and ROP (>0.05).
Compared with NIPPV, NHFOV can effectively remove CO and reduce the risk of reintubation, without increasing the incidence of complications such as BPD, air leak, nasal damage, PVL, and IVH, and therefore, it can be used as a sequential respiratory support mode for preterm infants after extubation.
系统评价无创高频振荡通气(NHFOV)与经鼻间歇正压通气(NIPPV)作为早产儿拔管后呼吸支持的有效性和安全性。
检索中国知网、万方数据、中国期刊全文数据库、中国生物医学光盘数据库、PubMed、Web of Science和Cochrane图书馆,查找截至2022年8月31日发表的关于NHFOV和NIPPV作为早产儿拔管后呼吸支持的文章。使用RevMan 5.4软件和Stata 17.0软件进行Meta分析,比较NHFOV组和NIPPV组之间的相关指标,包括拔管后72小时内的再插管率、转为无创辅助通气后6 - 24小时的二氧化碳分压(PCO),以及支气管肺发育不良(BPD)、气漏、鼻损伤、脑室周围白质软化(PVL)、脑室内出血(IVH)和早产儿视网膜病变(ROP)的发生率。
共纳入9项随机对照试验。Meta分析显示,与NIPPV组相比,NHFOV组拔管后72小时内的再插管率显著降低(=0.67,95%:0.52 - 0.88,=0.003),转为无创辅助通气后6 - 24小时的PCO也显著降低(=-4.12,95%:-6.12至-2.13,<0.001)。两组在BPD、气漏、鼻损伤、PVL、IVH和ROP等并发症的发生率方面无显著差异(>0.05)。
与NIPPV相比,NHFOV能有效排出CO并降低再插管风险,且不增加BPD、气漏、鼻损伤、PVL和IVH等并发症的发生率,因此可作为早产儿拔管后的序贯呼吸支持模式。